Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research focused on Cancer research and Lymphoma, with related work in EZH2, LIN28, Plasmablastic lymphoma. Notable publications include 'The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms', 'Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma', and 'Type II enteropathy‐associated T‐cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group'.
Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748
Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma
Bridging bytes and biopsies: A comparative analysis of ChatGPT and histopathologists in pathology diagnosis and collaborative potential
Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop
Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma
PRDM15 is a key regulator of metabolism critical to sustain B-cell lymphomagenesis
Molecular pathogenic pathways in extranodal NK/T cell lymphoma
Epstein–Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis
Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes
RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC
JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma
EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study
Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients
p53 haploinsufficiency and functional abnormalities in multiple myeloma
EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity
LIN28/LIN28B: An emerging oncogenic driver in cancer stem cells
Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype
Type II enteropathy‐associated T‐cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group
T-cell death following immune activation is mediated by mitochondria-localized SARM